查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198452

专业 PACS 市场——增长、趋势、COVID-19 影响和预测 (2023-2028)

Specialty Pacs Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 100 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，专业 PACS 市场预计将以 4.87% 的复合年增长率註册。

COVID-19 大流行对市场的增长产生了重大影响。 根据 2021 年 4 月 NCBI 的一篇文章，在过去的几十年里，大多数放射科不得不处理图像存檔和通信系统 (PACS) 等关键系统的意外停机。 在一项研究中，研究人员启用了家庭使用的 PACS 工作站并评估了系统性能。 从那时起，制定了各种指南，并且一些研究中心已经使 PACS 工作站的无线适配器能够在家中使用。 这些用于评估 PACS 的在家工作选项增加了对 PACS 的需求，并对研究市场的增长产生了积极影响。 此外，在大流行期间 PACS 的部署有所增加，领先的公司已经开始创新多种 PACS 模型以促进市场增长。 例如，2020 年 3 月，PACS 解决方案提供商 IMAGE Information Systems 推出了 www.disAIblecorona.com，为放射学界提供了一个收集和分享全球 COVID-19 病例、学习和抗击疾病的场所。 因此，COVID-19 对市场的增长产生了重大影响。

推动所研究市场增长的主要因素是可视化的使用越来越多、IT 架构和成像模式的结合，以及 PACS 被各种医学学科纳入实践。 例如，2021 年 12 月，AI 射线照相报告公司 Synapsica 将与 Wipro GE Healthcare 支持的医疗选项供应商 GenWorks Wellbeing 合作，将其 PACS 带到印度各地的城市。 该公司的 Radiolens 放射学工作流程解决方案定期检测有风险的高质量扫描，并为大多数典型模式进行初步研究。 这种分销协议也促进了市场的增长。

在 NCBI 于 2021 年 7 月发表的一篇研究论文中，日常临床工作无时无刻不在产生大量图像数据，导致檔案库的不断扩大和构建大规模医学图像存储库的新方法不断涌现。将在世界各地举行。 此外，JAMA 于 2021 年 10 月发表的另一篇论文指出，PACS 在医学影像领域的增长和进步的一个显着加速因素是数据存储成本的显着下降。 因此，预计该成本的额外好处将促进所研究市场的增长。

其他因素包括人口老龄化、各种疾病发病率增加、专业化 PACS 的好处、政府促进引入医疗 IT 解决方案的政策、诊断影像投资的增加以及医学影像的接受度提高在 IT 解决方案中，成像设备的使用增加预计将在预测期内推动市场增长。

特殊 PACS 市场趋势

On-premise 专用 PACS 有望在专用 PACS 市场占据最大市场份额

本地模型是传统的软件部署模型。 医疗机构和医院主要更喜欢本地数据存储来存储和管理患者数据。 现场交付，也称为内部部署模式，定义为供应商派遣合格员工到客户现场开发和交付软件的方法。 易于访问是推动本地软件解决方案增长的关键因素。 对于在多个国家/地区拥有远程位置的全球企业，由于带宽限制，访问云资源可能是一个挑战。

根据 NCBI 于 2021 年 8 月发表的一篇文章，临床医生和放射科医生主要依靠 PACS 进行图像显示和分析。 但是，在部署过程中学习新工具等效率低下，此用例的云采用阻碍了新的学习。 因此，从 2021 年 8 月起，Amazon Web Services (AWS) 将提供 VNA 等本地医疗成像工作站。

此外，2022 年 5 月在 Springer 上发表的一篇文章指出，本地软件是在物理办公室内部部署和维护的，而不是託管在供应商提供的云上。据说。 它们在公司监督下运行，系统和数据仍处于公司控制之下。 本地专门从事与现有业务系统的集成。 因此，与这种交付形式相关的安全性有望推动这一细分市场的增长。

此外，根据 Creo 在 2022 年 1 月更新的数据，非本地软件通常意味着如果软件本身已获得许可，则软件的整个实例驻留在组织和数据的前提下，额外的保护需要公司-购买许可证或要使用的软件副本。

因此，由于上述因素，在本研究的预测期内，现场（场所）部分预计会增长。

北美有望在预测期内主导市场

由于患者数量增加和老年人口增加等因素，预计在预测期内，北美将保持其在专业 PACS 市场的主导地位。 此外，该地区慢性病的增加、图像处理设备的技术进步、早期发现疾病的好处以及大公司进入该地区正在推动市场增长并确保在该地区的主导地位。成为一个因素。

此外，市场参与者的战略举措有望促进市场的增长。 2021 年 7 月，GE Healthcare 开发了名为 Edison True PACS 的下一代云图像存储和通信系统 (PACS)。 它是目前在美国可用的诊断成像和工作流程解决方案。

此外，在国内，PACS的临床应用也已经开始，因此需求不断增加并推动了市场的增长。 例如，2021 年 11 月，Change Healthcare 宣布了其 Stratus Imaging PACS 的临床可用性。 它是一种云原生、零占用空间的 PACS。 这个可扩展的云原生平台被美国的 StatRad 使用。 这种 PACS 的推出将促进研究市场的增长。

此外，市场参与者为营销、使用或开发新产品而采取的合併、收购和合作伙伴关係等战略举措也在推动市场增长。 例如，2022 年 4 月，皇家飞利浦公司和南卡罗来纳州最大的非营利性医疗保健系统之一 PrismaHealth 宣布，该医疗保健系统将实现企业互操作性、标准化患者监测并改善患者护理。双方签订了一项多年期协议，以推动企业成像解决方案的创新，以增强和改进临床性能。 这种伙伴关係也促进了市场的增长。

因此，上述因素预计将在预测期内推动该地区所研究市场的增长。

专业 PACS 市场竞争对手分析

专业 PACS 市场竞争激烈，由几家主要参与者组成。 在市场份额方面，几家主要参与者目前占据市场主导地位，一些知名参与者正在合作、收购和推出新产品以巩固其在全球的市场地位。 目前主导市场的公司包括 IBM 公司、爱克发医疗保健公司、富士胶片控股公司（富士医疗系统公司）、西门子股份公司和飞利浦医疗保健公司。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 扩大成像设备的使用
    • 慢性病负担加重
  • 市场製约因素
    • 数据安全和隐私问题
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按类型
    • 心血管 PACS
    • 用于骨科手术的 PACS
    • 肿瘤学 PACS
    • 其他类型
  • 按组件
    • 软件
    • 服务
    • 硬件
  • 按开发
    • 本地 PACS
    • Web/云类型专用 PACS
  • 最终用户
    • 医院
    • 诊断中心
    • 其他最终用户
  • 区域信息
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Agfa Healthcare
    • Canon USA Inc.
    • Fujifilm Holdings Corporation（Fujifilm Medical Systems）
    • IBM Corporation
    • McKesson Corporation
    • Novarad
    • Philips Healthcare
    • Sectra AB
    • Siemens AG
    • Topcon Corporation

第7章 市场机会与今后动向

简介目录
Product Code: 68681

The specialty PACS market is anticipated to register a CAGR of 4.87% during the forecast period.

The COVID-19 pandemic had a significant impact on the growth of the market. An article published by NCBI in April 2021 stated that over the past few decades, most radiology departments had to deal with unplanned downtimes of their critical systems, such as the picture archiving and communication system (PACS). During a study, researchers enabled their PACS workstation for home use and evaluated system performance. After that, various guidelines were made, and following that, several research centers allowed wireless adapters for PACS workstations for use at home. This work-from-home option for PACS for evaluation purposes increased the demand for the same, thereby impacting the growth of the market studied positively. Moreover, the implementation of PACS increased during the pandemic, and major players started innovating several PACS models to boost the growth of the market. For instance, in March 2020, IMAGE Information Systems, a provider of PACS solutions, launched www.disAIblecorona.com to offer the radiology community a place to collect and share worldwide COVID-19 cases to learn and fight the disease. Thus COVID-19 had a significant impact on the growth of the market.

The significant factors for the growth of the market studied are the growing use of visualization, the collaborations between IT structures and imaging modalities, and diverse medical fields incorporating PACS in their practice. For instance, in December 2021, AI radiology reporting firm Synapsica partnered with GenWorks Well being, a healthcare options supplier backed by Wipro GE Healthcare, to deliver its PACS to cities across India. Its Radiolens radiology workflow resolution routinely detects dangerous high-quality scans and creates preliminary studies for most typical modalities. Such distribution agreements are also boosting the growth of the market.

A research article published by NCBI in July 2021 stated that large amounts of imaging data are constantly generated in daily clinical practice, leading to continuously expanding archives, and new progressive efforts are being made worldwide to build large-scale medical imaging repositories. Furthermore, another article published by JAMA in October 2021 stated that an important accelerator for the growth and advancements of PACS in medical imaging is the huge drop in the cost of data storage. Thus, this added advantage of cost is anticipated to boost the growth of the market studied.

Additionally, the growing elderly population, successive growth in the occurrence of different diseases, benefits affiliated with specialty PACS, government measures to boost the implementation of medical IT solutions, rise in investments in diagnostic imaging, increase in acceptance of medical imaging IT solutions, and the growing use of imaging equipment are likely to boost the growth of the market studied during the forecast period.

Specialty PACS Market Trends

On-premise Specialty PACS are Expected to Hold the Largest Market Share in the Specialty PACS Market

The on-site model is the traditional model of software implementation. Healthcare facilities and hospitals largely prefer on-premise data storage to store and manage patient data. Onsite delivery is often called on-premise mode and is defined as a way of software development and delivery when vendors send their qualified employees to the client's site. Accessibility is the major factor driving the growth of on-premise software solutions. Access to cloud resources can pose a challenge due to bandwidth constraints for global companies with remote sites in multiple countries.

An article published by NCBI in August 2021 stated that clinicians and radiologists mostly rely on PACS to view and analyze images. But if any added inefficiency, such as learning new tools, is needed at the time of implementation, then cloud adoption for this use case would be a blocker for new learning. Hence, Amazon Web Services (AWS) have been offering on-premise medical imaging workstations such as VNA since August 2021.

Additionally, an article published in Springer in May 2022 stated that on-premise software is deployed and maintained in-house at a physical office instead of hosted on a vendor-supplied cloud. These run under company supervision, while the systems and data remain under the company's control. On-premise mode of delivery allows specialized integration with other existing business systems. Thus, the security associated with the mode of delivery is expected to drive the growth of the segment.

Moreover, as per the data updated by Cleo in January 2022, non-premise software requires a license purchased by the enterprise or a copy of the software to use it because when the software itself is licensed, the entire instance of the software resides within an organization's premises, and there is generally greater protection of data.

Thus, owing to the above-mentioned factors, the on-site (premise) segment is expected to grow during the forecast period of the study.

North America is Expected to Dominate the Market During the Forecast Period

North America is expected to maintain its dominance in the specialty PACS market during the forecast period, owing to factors such as the growing patient pool and rising geriatric population. Furthermore, the rising prevalence of chronic diseases in the region, technological advancement in imaging modalities, early disease detection benefits, and the domicile presence of some key players in the region are driving the growth of the market and are responsible for ensuring dominance in the region.

Additionally, the strategic initiatives by market players are expected to contribute to the growth of the market. In July 2021, GE Healthcare developed a next-generation, cloud-based picture archive and communication system (PACS) named Edison True PACS. It is a diagnostic imaging and workflow solution that is currently available in the United States.

Furthermore, the initiation toward the clinical use of PACS in the country is also increasing the demand, thereby driving the growth of the market. For instance, in November 2021, Change Healthcare reported that Stratus Imaging PACS is in clinical use. It is a cloud-native, zero-footprint PACS. This scalable, cloud-native platform is used by StatRad in the United States. Such initiations in the use of the PACS also propel the growth of the market studied.

Additionally, the strategic initiatives taken by the market players, such as mergers, acquisitions, and partnerships for the marketing, usage, or development of new products, are also driving the growth of the market. For instance, in April 2022, Royal Philips and Prisma Health, one of South Carolina's largest non-profit healthcare systems, entered into a multi-year agreement to help the health system achieve enterprise interoperability, standardize patient monitoring, and drive innovation in enterprise imaging solutions to enhance patient care and improve clinical performance. Such partnerships are also boosting the growth of the market.

Thus the above-mentioned factors are expected to drive the growth of the market studied in the region during the forecast period.

Specialty PACS Market Competitor Analysis

The specialty PACS market is competitive and consists of a few major players. In terms of market share, some major players have been currently dominating the market, and some prominent players have been vigorously making collaborations, acquisitions, and launching new products with other companies to consolidate their market positions across the world. Some of the companies, which are currently dominating the market, are IBM Corporation, Agfa Healthcare, Fujifilm Holdings Corporation (Fujifilm Medical Systems), Siemens AG, and Philips Healthcare.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Use of Imaging Devices
    • 4.2.2 Growing Burden of Chronic Diseases
  • 4.3 Market Restraints
    • 4.3.1 Data Security and Privacy Issues
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Cardiovascular PACS
    • 5.1.2 Orthopedic PACS
    • 5.1.3 Oncology PACS
    • 5.1.4 Other Types
  • 5.2 By Component
    • 5.2.1 Software
    • 5.2.2 Services
    • 5.2.3 Hardware
  • 5.3 By Development
    • 5.3.1 On-premise Specialty PACS
    • 5.3.2 Web/Cloud-based Specialty PACS
  • 5.4 By End User
    • 5.4.1 Hospitals
    • 5.4.2 Diagnostic Centers
    • 5.4.3 Other End Users
  • 5.5 By Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agfa Healthcare
    • 6.1.2 Canon USA Inc.
    • 6.1.3 Fujifilm Holdings Corporation (Fujifilm Medical Systems)
    • 6.1.4 IBM Corporation
    • 6.1.5 McKesson Corporation
    • 6.1.6 Novarad
    • 6.1.7 Philips Healthcare
    • 6.1.8 Sectra AB
    • 6.1.9 Siemens AG
    • 6.1.10 Topcon Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS